Access cutting-edge breast cancer treatment through this clinical trial at a research site in Hinsdale. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Hinsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is a Phase 1b/2, open-label, parallel-arms pilot study in men and post-menopausal women with hormone receptor positive (HR+), HER2- advanced or metastatic breast cancer with an alteration in the PI3K pathway, including a mutation of the PIK3CA gene, PTEN loss, or AKT1 mutation, designed to determine the safety of evexomostat (SDX-7320) plus standard of care treatment alpelisib (BYL-719) or capivasertib and fulvestrant (each combined, the 'triplet therapy'), to measure the severity and numbe
Sponsor: SynDevRx, Inc.
Check if you qualify for this breast cancer clinical trial in Hinsdale, IL
If you're searching for breast cancer treatment options in Hinsdale, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hinsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.